CDChandra Devi

Chandra Devi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chandra Devi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnosis of Kidney Diseases: A Spotlight on Genetic Testing

    by Chandra Devi, Parimal Das

    Kidney diseases are a significant burden on public health, necessitating improved diagnostic strategies for timely interven tion and management. Genetic testing has emerged as a promising approach to enhance the diagnosis of different diseases by uncovering underlying genetic factors. Genetic testing offers numerous advantages in the diagnosis of kidney diseases, including the identification of specific genetic variants associated with various kidney conditions. With a high burden of kid ney diseases in developing countries, genetic testing holds immense promise in providing accurate and timely diagnoses and managing these conditions. This approach enables clinicians to determine the genetic basis of kidney diseases, facili tating personalized treatment plans and family counseling. This article highlights the availability and accessibility of kidney genetic testing facilities, exploring the advancements made in this field. It also addresses the unique challenges faced by the developing countries’ population, such as genetic heterogeneity and diverse ethnic backgrounds, which necessitate tailored approaches for genetic testing. It addresses the ethical considerations surrounding genetic testing and the impor tance of informed consent and genetic counseling services. In conclusion, this article emphasizes the growing significance of genetic testing in the diagnosis of kidney diseases, emphasizing its potential to revolutionize patient care and improve outcomes and the need for further research and collaborative efforts to establish standardized guidelines and protocols. Cite this article as: Devi C, Das P. Diagnosis of kidney diseases: A spotlight on genetic testing. Turk J Nephrol. 2026;35(1):4-14.

  • Open Access

    Pan-Omics Fusion and Machine Learning Unveil Congenital Tooth Agenesis-Ecto-mesodermal Diseases Link and Biomarker Discovery

    by Prashant Ranjan, Chandra Devi, Vinay Kumar Srivastava, Meenakshi Chandel, Garima Jain, Parimal Das

    Background: Congenital tooth agenesis (CTA) is a common developmental anomaly with complex genetic and molecular mechanisms. Previous studies have primarily focused on candidate gene mutations, often lacking a pan-omics perspective. Methods: This study integrates metabolomics, proteomics, microarray, and genomics with machine learning to identify biomarkers and elucidate disease mechanisms. A random forest-based classification achieved high AUC-ROC scores (0.95 for proteomics, 0.98 for metabolomics), validating the biomarker discovery framework. Results: Several biomarkers were identified in this study that enhance our understanding of CTA. Furthermore, our findings reveal a significant association between CTA and ecto-mesodermal diseases, which has not been extensively explored before. Notably, 24 dual-expression genes were expressed in both pre- and post-developmental stages, suggesting a regulatory role in tooth integrity, repair, and homeostasis. Metabolomics analysis revealed 28 upregulated and 17 downregulated metabolites uniquely associated with CTA. Key metabolic alterations involved nucleotide metabolism, purine metabolism, oxidative stress, and Wnt signaling. High-performing metabolites (AUC ≥ 0.90), including PEG n5 (0.99), PEG n6 (0.98), PEG-4 (0.97), PEG n7 (0.96), PEG n8 (0.95), caffeine (0.94), hydroxycaproic (0.91) and alpha-aspartylphenylalanine (0.90) demonstrated strong diagnostic potential. CTA patients showed 292 unique metabolites vs. 238 in controls, indicating metabolic pathway alterations. Proteomic analysis identified 76 upregulated and 33 downregulated genes, with key biomarkers [ SERPINA1 (0.92), PZP (0.90), FGA (0.91), TLN1 (0.94), FGB (0.95)] displaying AUC-ROC ≥ 0.90. Pan-omics fusion followed by STRING analysis identified 20 central hub genes strongly correlated with congenital tooth agenesis signaling. Conclusion: This study pioneers the systemic association of CTA with ecto-mesodermal diseases, revealing novel signatures, disrupted pathways, and therapeutic targets. Graphical


  • Open Access

    Novel Ectodysplasin-A Variants: Structural and Functional Basis of Hypohidrotic Ectodermal Dysplasia

    by Prashant Ranjan, Chandra Devi, Rajesh Bansal, Vandita Srivast, Vinay Kumar Srivast, Parimal Das

    This study investigates two novel variants in the EDA, c.680G > A (p.G227E) and c.649_666del (Δ215–220), identified in X-linked ectodermal dysplasia and syndromic tooth agenesis cases. These variants were identified through Sanger sequencing and mapped to highly conserved regions of EDA. Bioinformatics tools consistently classified them as deleterious, with significant disruptions predicted in protein stability, hydrophobicity, and secondary structure. Structural analysis revealed that p.G227E caused a glycine-to-glutamic acid substitution, altering hydrophobicity and secondary structure, while Δ215–220 disrupted a conserved hydrophobic region, leading to increased protein instability Functional studies revealed reduced expression of EDA and WNT4 proteins, alongside increased IκB levels and decreased NF-κB mRNA expression, indicating impaired EDA-NF-κB signaling. Subcellular localization analyses demonstrated diminished cytoplasmic expression of the EDA Variants proteins, corroborated by in silico predictions. Post-translational modifications (PTMs) and gene ontology (GO) analyses revealed alterations in processes critical for ectodermal development, including macromolecule biosynthesis, nitrogen metabolism, and receptor signaling. Molecular dynamics simulations highlighted increased rigidity, compact structure, and reduced flexibility in the EDA variants proteins compared to EDA Wild Type (WT). Interestingly, neither variant significantly impacted calcium or mitochondrial potential under normal experimental conditions, suggesting their pathogenic effects arise primarily from disrupted protein interactions and signaling pathways. This study integrates molecular, bioinformatics, and functional analyses to elucidate the pathogenicity of these novel EDA variants, providing insights into ectodermal dysplasia mechanisms and paving the way for future therapeutic strategies targeting these EDA variants.


  • Open Access

    Role of MicroRNAs in Autosomal Dominant Polycystic Kidney Disease: Expression Profiles and Pathway Analysis

    by Chandra Devi, Prashant Ranjan, Jitendra Kumar Mishra, Shivendra Singh, Parimal Das

    This study investigates the role of specific microRNAs (miRNAs) in autosomal dominant polycystic kidney disease (ADPKD). Network analysis using Cytoscape 3.10.1 revealed 28 miRNAs that target two or more PKD related genes, while 14 miRNAs interacted with three or more genes. Pathway analysis of these 14 miRNAs, conducted via the miRPath V4.0 tool, utilized various resources such as KEGG, GO terms, Pfam, and MSigDB, highlighting their functional roles in ADPKD. Among these 14 miRNAs, four were prioritized for further analysis based on the higher number of target genes and existing evidence of their expression in blood. These miRNAs were analyzed for fold change expression levels using qRT-PCR on blood-derived RNA samples from ADPKD patients (n=19) and healthy controls (n=5). These four miRNAs—hsa-miR20a-5p, hsa-miR27b-3p, hsa-miR3613-3p, and hsa-miR181a-5p— showed significant upregulation with p-values of 0.0179, 0.0002, 0.0166, and 0.0402 respectively. The functional enrichment of miRNAs involved in PKD evidently suggests that these play diverse roles in regulating key processes such as cell cycle progression, mTOR signaling, autophagy, EMT, and cellular responses to hypoxia thus playing crucial role in the pathogenesis of ADPKD and could serve as potential biomarkers or therapeutic targets.

  • Open Access

    Understanding Tooth Agenesis: A Multi-omics Insight into MicroRNA Regulation

    by Prashant Ranjan, Chandra Devi, Neha Verma, Rajesh Bansal, Vinay Kumar Srivastava, Parimal Das

    This study reveals novel microRNAs (miRNAs) implicated in congenital tooth agenesis (CTA), a common dental anomaly with a complex genetic basis. Through a multi-omics approach combining bioinformatics, whole exome sequencing, metabolite analysis, and gene expression profiling, we identified eight key miRNAs potentially involved in tooth development. Among these, four miRNAs viz. miR-218-5p, miR-15b-5p, miR-200b-3p, and let-7a-3p were validated as significant regulators in CTA, marking their first investigation in blood samples from CTA patients. Our analysis revealed that these miRNAs play critical roles in odontogenesis, influencing essential signaling pathways, including Wnt, FGF , and PI3 kinase pathways. Among these four, miR-218-5p and let-7a-3p emerged as key players in dental tissue morphogenesis, each contributing to previously unidentified networks crucial for tooth development. This study highlights the potential of these miRNAs as non-invasive biomarkers for early CTA diagnosis and therapeutic targets. This is the first comprehensive investigation of these specific miRNAs in CTA, utilizing a multi-omics approach to offer fresh insights into miRNA-mediated mechanisms and their role in regulating dental anomalies. Our findings not only advance the understanding of the genetic regulation of tooth development but also pave the way for personalized approaches in managing dental anomalies. Further research is needed to validate these results and explore their clinical applications. Graphical


  • Computational exploration of protein structure dynamics and RNA structural consequences of PKD1 missense variants: implications in ADPKD pathogenesis

    by Chandra Devi, Prashant Ranjan, Sonam Raj, Parimal Das

    We analyzed the impact of nine previously identified missense PKD1 variants from our studies, including c.6928G > A p.G2310R, c.8809G > A p.E2937K, c.2899 T > C p.W967R, c.6284A > G p.D2095G, c.6644G > A p.R2215Q, c.7810G > A p.D2604N, c.11249G > C p.R3750P, c.1001C > T p.T334M, and c.3101A > G p.N1034S on RNA structures and PC1 protein structure dynamics utilizing computational tools. RNA structure analysis was done using short RNA snippets of 41 nucleotides with the variant position at the 21st nucleotide, ensuring 20 bases on both sides. The secondary structures of these RNA snippets were predicted using RNAstructure. Structural changes of the mutants compared to the wild type were analyzed using the MutaRNA webserver. Molecular dynamics (MD) simulation of PC1 wild-type and mutant protein regions were performed using GROMACS 2018 (GROMOS96 54a7 force field). Findings revealed that five variants including c.8809G > A (p.E2937K), c.11249G > C (p.R3750P), c.3101A > G (p.N1034S), c.6928G > A (p.G2310R), c.6644G > A (p.R2215Q) exhibited major alterations in RNA structures and thereby their interactions with other proteins or RNAs affecting protein structure dynamics. While certain variants have minimal impact on RNA conformations, their observed alterations in MD simulations indicate impact on protein structure dynamics highlighting the importance of evaluating the functional consequences of genetic variants by considering both RNA and protein levels. The study also emphasizes that each missense variant exerts a unique impact on RNA stability, and protein structure dynamics, potentially contributing to the heterogeneous clinical manifestations and progression observed in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients offering a novel perspective in this direction. Thus, the utility of studying the structure dynamics through computational tools can help in prioritizing the variants for their functional implications, understanding the molecular mechanisms underlying variability in ADPKD presentation and developing targeted therapeutic interventions.


  • Open Access

    Computational Exploration of Protein Structure Dynamics and RNA structural Consequences of PKD1 Missense Variants: Implications in ADPKD Pathogenesis

    by Chandra Devi, Prashant Ranjan, Sonam Raj, Parimal Das

    Autosomal dominant polycystic kidney disease (ADPKD), a genetic disorder characterized by the formation of fluid-filled cysts within the kidneys, leading to progressive renal dysfunction, is primarily caused by mutations in PKD1 , a gene encoding for the protein polycystin-1 (PC1). Understanding the structural consequences of PKD1 variants is crucial for elucidating disease mechanisms and developing targeted therapies. In this study, we analyzed the effects of nine missense PKD1 variants, including c.6928G>A p.G2310R, c.8809G>A p.E2937K, c.2899T>C p.W967R, c.6284A>G p.D2095G, c.6644G>A p.R2215Q, c.7810G>A p.D2604N, c.11249G>C p.R3750P, c.1001C>T p.T334M, and c.3101A>G p.N1034S on RNA structures, their interactions utilizing computational tools. We also explain the effects of these variants on PC1 protein dynamics, stability, and interactions using molecular dynamics (MD) simulation. These variants are located at crucial domains such as the REJ domain, PKD domains, and cation channel domain, potentially compromising PC1’s function and contributing to ADPKD pathogenesis. Findings reveal substantial deviations in RNA structures and their interactions with other proteins or RNAs and also protein structure and dynamics for variants such as c.8809G>A (p.E2937K), c.11249G>C (p.R3750P), c.3101A>G (p.N1034S), c.6928G>A (p.G2310R), c.6644G>A (p.R2215Q) suggesting their potential implications in disease etiology. The study also suggests that although certain variants may have minimal effects on RNA conformations, their observed alterations in MD simulations indicate potential impact on protein structure dynamics highlighting the importance of evaluating the functional consequences of genetic variants by considering both RNA and protein levels. This study offers valuable perspectives of the utility of studying the structure dynamics through computational tools in prioritizing the variants for their functional implications and understanding the molecular mechanisms underlying ADPKD pathogenesis and developing therapeutic interventions. GRAPHICAL


  • Open Access

    A Whole Exome Sequencing Study of a small Indian Autosomal Dominant Polycystic Kidney Disease Patient Cohort

    by Chandra Devi, Shivendra Singh, Bhagyalaxmi Mohapatra, Ashok Kumar, Sanjay Vikrant, Rana Gopal Singh, Pradeep Kumar Rai, Parimal Das

    Autosomal Dominant Polycystic Kidney Disease is characterized by renal cyst development, often leading to kidney enlargement and failure. We conducted whole exome sequencing on 14 participants (12 families) from an Indian cohort. Our analysis revealed a spectrum of genetic variants, predominantly in the PKD1. These in PKD1 included missense variants such as p.Glu2937Lys (c.8809G>A) and p.Gly2310Arg (c.6928G>A), p.Asp2095Gly (c.6284A>G), p.Thr938Met (c.2813C>T), p.Trp967Arg (c.2899T>C), p.Glu593* (c.1777G>T), frameshift variants p.Gln149fs*141 (c.445delC), p.Ser3305fs*84 (c.9914_9915delCT), p.His1347fs*83 (c.4041_4042delCA), and p.Leu2776fs*87(c.8327_8363delTGGCGGGCGAGGAGATCGTGGCCCAGGGCAAGCGCTC), intronic splice site variant c.8017-3C>G, nonsense variant p.Glu593* (c.1777G>T) and in PKD2 missense variant p.Ser370Asn (c.1109G>A). While one individual carried intronic (c.2358+5G>A) and 3’UTR (c.*174G>T) variants in PKD2 only another individual carried variants in both PKD1 and PKD2 , suggesting potential genetic complexity. Clinical data revealed diverse presentations. Age at diagnosis varied widely. Patients with frameshift variants exhibited earlier onset and severe manifestations, including bilateral ADPKD. One proband had right unilateral ADPKD. Involvement of liver, a common extra-renal manifestation, was also observed. Heterogeneity at phenotypic and at allelic level was observed in our cohort. In this study, using WES of a trio, a frameshift-truncation deletion [c.32del/p.Leu11ArgfsTer61] in MIOX was found to be associated with the disease shared by both the affected and early diagnosed mother and daughter carrying PKD1 missense variant, which had not been previously reported in ADPKD. Further, differential gene expression analysis using data from GEO database showed reduced MIOX expression in ADPKD cystic samples compared to minimal cystic tissues and controls. MIOX is an enzyme specific to renal tubules and catalyses the initial step of the kidney-based myoinositol catabolism. Both affected candidates also shared benign variants and other variations of uncertain significance which may influence the disease development. Further functional analysis will clarify how MIOX contributes to the disease. The study limitations include the small sample size and the need for validation in larger cohorts. Our findings highlight the importance of genetic analysis in ADPKD management especially to facilitate personalized therapeutic strategies. Highlights: Identified variants in PKD1 and PKD2 through whole exome sequencing in ADPKD patients, affecting different protein regions. Variants include non-synonymous coding changes, frame-shift deletions, and splice site alterations. Clinical features and age at diagnosis varied widely, with common symptoms including flank pain, fatigue. Frameshift deletion in MIOX , associated in one PKD1 trio, implicates its role in ADPKD pathogenesis. DGE analysis of dataset from database reveals downregulation of MIOX in ADPKD tissue samples highlighting its role in potential molecular pathways in ADPKD progression. Graphical


  • Open Access

    Impact of B.1.617 and RBD SARS-CoV-2 variants on vaccine efficacy: An in-silico approach

    by Prashant Ranjan, Neha Neha, Chandra Devi, Garima Jain, Chandana Basu Mallick, Parimal Das